4//SEC Filing
Kite Pharma, Inc. 4
Accession 0001209191-17-040615
CIK 0001510580operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:43 PM ET
Size
5.5 KB
Accession
0001209191-17-040615
Insider Transaction Report
Form 4
Ruchefsky Steven B
Director
Transactions
- Sale
Common Stock
2017-06-14$89.48/sh−20,000$1,789,574→ 205,426 total
Footnotes (2)
- [F1]The reporting person's sale of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,400 shares, with the reporting person's purchase of 1,400 shares of the Issuer's common stock at a price of $69.50 per share on May 9, 2017. The reporting person has agreed to pay to the Issuer, upon settlement of the trade, $28,945 representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.25 to $90.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Kite Pharma, Inc.
CIK 0001510580
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001510580
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:43 PM ET
- Size
- 5.5 KB